Remme W J, de Leeuw P W, Bootsma M, Look M P, Kruijssen D A
Zuiderziekenhuis and Sticares Foundation, Rotterdam, The Netherlands.
Am J Cardiol. 1991 Jul 15;68(2):181-6. doi: 10.1016/0002-9149(91)90741-3.
To identify the effect of myocardial ischemia on systemic neurohormones and vascular resistance, 32 untreated, normotensive patients with coronary artery disease underwent incremental atrial pacing until angina. Arterial and coronary venous lactate and arterial values of catecholamines and angiotensin II were determined at control, at maximal pacing rates, and at 1, 2, 5 and 30 minutes after pacing. Based on pacing-induced ST-segment depression (greater than or equal to 0.1 mV) or myocardial lactate production, or both, patients were selected as ischemic (n = 25) or nonischemic (n = 7). Baseline clinical and hemodynamic data were comparable. During pacing, chest pain was similar (20 ischemic vs 7 nonischemic patients). Also, hemodynamic measurements were comparable, except for contractility, which did not improve, and left ventricular end-diastolic pressure, which significantly increased in ischemic patients. Moreover, during ischemia arterial pressures increased significantly (13%) and systemic resistance increased from 1,470 +/- 60 (control) to 1,632 +/- 76 dynes.s.cm-5 5 minutes after pacing (p less than 0.05) in ischemic but not in nonischemic patients. Pacing did not affect neurohormones in nonischemic patients. In contrast, norepinephrine in ischemic patients increased significantly from 1.7 +/- 0.2 (control) to 2.6 +/- 0.3 (maximal pacing) and to 3.0 +/- 0.4 nmol/liter (1 minute after pacing), whereas angiotensin II levels increased from 6.2 +/- 1.4 (control) to 9.3 +/- 2.1 pmol/liter (1 minute after pacing, p less than 0.05). Epinephrine only increased during maximal rates (0.9 +/- 0.1 vs 0.6 +/- 0.1 nmol/liter at control, p less than 0.05). Thus, myocardial ischemia activates circulating catecholamines and angiotensin II, accompanied by systemic vasoconstriction.(ABSTRACT TRUNCATED AT 250 WORDS)
为了确定心肌缺血对全身神经激素和血管阻力的影响,32例未经治疗的血压正常的冠心病患者接受递增性心房起搏直至诱发心绞痛。在对照状态、最大起搏率时以及起搏后1、2、5和30分钟时,测定动脉血和冠状静脉血中的乳酸水平以及动脉血中儿茶酚胺和血管紧张素II的水平。根据起搏诱发的ST段压低(大于或等于0.1 mV)或心肌乳酸生成情况,或两者兼有,将患者分为缺血组(n = 25)和非缺血组(n = 7)。基线临床和血流动力学数据具有可比性。起搏期间,胸痛情况相似(20例缺血患者与7例非缺血患者)。此外,血流动力学测量结果具有可比性,但收缩性未改善,缺血患者的左心室舒张末期压力显著升高。而且,在缺血期间,缺血患者的动脉压显著升高(13%),全身阻力从起搏前的1470±60(对照)增加到起搏后5分钟时的1632±76达因·秒·厘米⁻⁵(p<0.05),而非缺血患者则无此变化。起搏对非缺血患者的神经激素无影响。相比之下,缺血患者的去甲肾上腺素水平从1.7±0.2(对照)显著增加到2.6±0.3(最大起搏时),并在起搏后1分钟时增加到3.0±0.4纳摩尔/升,而血管紧张素II水平从6.2±1.4(对照)增加到9.3±2.1皮摩尔/升(起搏后1分钟,p<0.05)。肾上腺素仅在最大起搏率时增加(对照时为0.9±0.1与0.6±0.1纳摩尔/升,p<0.05)。因此,心肌缺血激活循环中的儿茶酚胺和血管紧张素II,并伴有全身血管收缩。(摘要截短至250字)